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Introduction
Epilepsy affects approximately 1% of the general
population.1 Despite modern anticonvulsant therapy
and serum drug level monitoring techniques, between
20% and 30% of patients with epilepsy are refractory
to all forms of medical treatment.2 Chronically intract-
able epilepsy is not only psychosocially disabling,
but also biologically damaging. Uncontrolled seizures
may result in ongoing neuronal damage, neuropsycho-
logical deficits, and increased risks of injury or
sudden death.3
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Temporal lobe resection for intractable epilepsy: review
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Objective. To review the management of medically intractable epilepsy by performing temporal lobe resection.
Design. Retrospective study.
Setting. University teaching hospital, Hong Kong.
Patients. Eleven patients: seven women and four men (mean age, 28 years; range, 19-49 years) who underwent
temporal lobe resection for intractable epilepsy from 1994 through 1998.
Main outcome measures. Preoperative and operative aspects of treatment, postoperative complications,
mortality, and seizure control before and after surgery.
Results. All but one patient had long-standing medically intractable temporal lobe epilepsy; the duration
between the onset of seizure and surgery ranged from 12 to 27 years (mean, 17.2 years). A total of 12 resections
were performed without any mortalities or major postoperative complications. After surgery, two patients
became seizure-free without the need for antiepileptic medication; six patients were seizure-free but required
medication; and two patients showed >90% of improvement in seizure control, whereas one patient showed
between 50% and 90% of improvement. Nine (81%) of the 11 patients reported significant improvement in
their social life and performance of daily activities. Two (18%) patients, including one with improved seizure
control, reported no improvement in their performance of daily functions.
Conclusions. Temporal lobe resection can produce significant improvements in patients who have medically
intractable epilepsy. The risks of surgery are relatively small and justifiable.
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Although epidemiological data on epilepsy in
Hong Kong are not available, the proportion of epi-
leptic patients in Hong Kong whose seizure control
is considered unsatisfactory has been estimated to
be 27%4 and 40%5 in two studies. For this group of
patients with medically intractable epilepsy, surgery
may improve the quality of life by achieving complete
or maximal seizure control without causing added
neurological deficit.
A large number of surgical procedures have been
described, including cortical resection (eg temporal
lobe resection),6 lesionectomy (eg tumour resection),7
hemispherectomy,8 and disconnection procedures such
as multiple subpial transections9 and corpus callo-
sotomy.10 Examples of other methods are chronic
electrical stimulation of the vagus nerve,11 chronic cere-
bellar stimulation,12 and stereotactic thalamic stimula-
tion.13 The choice of surgical procedure depends on
the precise localisation of the focus of epilepsy.
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Complex partial seizure is the type of epilepsy
that is most frequently refractory to medical therapy.14
The majority of cases involve the temporal region of
the brain (temporal lobe seizure or temporal lobe
epilepsy); other cases may arise from the frontal,
parietal, or occipital lobes (extra–temporal lobe epi-
lepsy). As a result, temporal lobe resection (ie cortical
resection) is the most widely and most effective method
used. The most common pathological findings in
patients who undergo temporal lobe surgery is mesial
temporal sclerosis or hippocampal sclerosis, which is
characterised by atrophy and gliotic changes of the
structures of the medial temporal lobe.15 Patients with
intractable temporal lobe epilepsy that is associated
with hippocampal sclerosis respond particularly well
to surgery and constitute the largest group of epileptic
patients who benefit from surgical treatment.
The Epilepsy Surgery Programme at the Queen
Mary Hospital (QMH) was initiated in 1993, and is a
multidisciplinary venture involving the departments
of medicine, neurosurgery, paediatrics, psychiatry,
nuclear medicine, and diagnostic radiology. In this
review, we report on our early experience with patients




Records of all the patients who had undergone tem-
poral lobe resections for medically intractable epilepsy
in the Department of Surgery at the QMH from 1994
through 1998 were reviewed. Medically intractable
epilepsy is defined as epilepsy that remains per-
sistent despite using an adequate therapeutic trial of
phenytoin and carbamazepine—both alone or in com-
bination—such that appropriate serum drug levels
are reached, and despite using a regimen of several
second-line antiepileptics for a duration of more
than 2 years. Only patients who had evidence of
hippocampal sclerosis or non-specific temporal lobe
pathology were included. Patients who had received
other treatment modalities or who had undergone
temporal lobe resection for other pathologies such as
tumours or vascular malformations (ie lesionectomy)
were not included, even if epilepsy was the primary
indication for surgery.
Box 1 shows the initial selection criteria for pa-
tients entering the Epilepsy Surgery Programme.
The degree of functional capacity due to intractable
seizure was mainly based on clinical history and neuro-
pyschological assessment; specific references were
made to employment, education, social, and psycho-
logical well-being. Patients who fulfilled these criteria
were subjected to a series of preoperative assessments
(Table 1). The aim of the preoperative evaluation was
to define precisely the epileptic focus in each patient
and the extent of resection that would produce the
maximum reduction in seizure and the minimum
functional deficit. Suitable candidates needed to have
Box 1. Selection criteria for epilepsy surgery
• Functionally incapacitating seizures
• Refractory to medical treatment
• Chronic seizure (>2 years duration)
• Intelligent patient (IQ >70)
• No major contra-indications to surgery
• Patient can cooperate with preoperative studies
• Age is not a contra-indication but 15-50 years is optimum
• No history of habitual non-compliance or chronic drug
abuse
Table 1. Results of preoperative assessment
Patient Sex/age EEG* MRI† SPECT‡ Language§ Memoryxx Focus¶
(years)
1 F/49 Right Right HS** Normal Left Left Right
2 F/33 Left Normal Bilateral Bilateral Right Left
3 M/19 Right Right cyst Right Left Bilateral Right
4 M/28 Bilateral Right HS Right Left Left Right
5 F/27 Right Right HS Bilateral Left Bilateral Right
6 F/21 Left Left HS Left Left Right Left
7 F/35 Bilateral Right HS Right Left Left Right
8 F/21 Left Left HS Bilateral Left Right Left
9 M/27 Right Right HS Right Bilateral Left Right
10 F/27 Right Right HS Right Left Left Right
11 M/25 Right Right HS Right Left Left Right
* Temporal lobe with primary epileptic focus on inter-ictal or ictal video-electroencephalography†
 Temporal lobe abnormality on magnetic resonance image‡
 Temporal lobe that shows hypoperfusion on inter-ictal single-positron emission computed tomography scan§
 Cerebral hemisphere supporting language function (from the Wada test)
xx
 Cerebral hemisphere supporting memory function (from the Wada test)¶
 Temporal lobe concluded to be containing the primary focus
** HS hippocampal sclerosis
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an identifiable unilateral epileptic focus over the
anterior temporal lobe area after complete evaluation.
In addition, resection of this area should not result in
any unacceptable neurological deficit such as aphasia
or memory impairment. Informed consent was obtained
from each patient and the next of kin after a formal
interview was conducted.
Preoperative assessment
History and clinical examination
The adequacy of medication trials previously used was
assessed to ensure that the patient was truly refractory
to medical therapy. Detailed information on the
types, frequency, severity, and duration of seizure was
obtained to help localise the focus of epilepsy. The
extent of disability (including psychiatric morbidity)
due to uncontrolled seizure, general physical fitness,
and the past medical history or other intracranial path-
ology were assessed. Focal neurological or cognitive
abnormalities that became evident during the clinical
examination also provided important information.
Non-invasive electroencephalography
Although consistent and lateralised epileptiform
discharges (eg spikes and slow-wave complexes) on
inter-ictal scalp electroencephalograms may theor-
etically provide adequate focus identification, video-
electroencephalography (EEG) recording was performed
for all patients who were being assessed. Ictal EEG
facilitated the localisation of the primary epileptic
focus by recording the electrical events at the scalp at
the onset of spontaneous seizure. The method identified
patients who had pseudoseizure or multifocal seizure,
both of which would constitute contra-indications
to surgery. The procedure was carried out on an in-
patient basis and the administration of antiepileptics
was tapered to increase the probability of recording a
seizure. With the use of synchronous 24-hour video
and scalp-electrode monitoring systems, EEG changes
can be directly correlated with clinical events. An ideal
candidate should demonstrate a unilateral primary
focus at the anterior temporal lobe during the onset of
a ‘typical’ seizure.
Magnetic resonance imaging
Magnetic resonance imaging (MRI) identified struc-
turally abnormal areas and hence probable epileptic
foci, which may not be identifiable on conventional
computed tomography scans. All patients who under-
went temporal lobe resections received an MRI
examination preoperatively. Hippocampal sclerosis
was seen as asymmetrical atrophy of the hippo-
campus over the medial temporal lobe and was
characteristically hyperintense on T2-weighted images
(Fig 1). Patients who were found to have pathology
other than hippocampal sclerosis on the MRI scan
(eg ganglioglioma or arteriovenous malformation)
were treated accordingly and were excluded from
this study. Normal findings on the MRI scan did not
exclude the patients from further assessment.
Single-photon emission computed tomography
Single-photon emission computed tomography
(SPECT) was used to demonstrate characteristic
changes in local blood flow in epileptogenic areas of
the brain. The radioactively labelled compound hexa-
methylpropylene-amino oxime passes the blood-brain
barrier and is retained by brain cells. Because its
uptake is a function of both regional cerebral blood
flow and the characteristics of the perfused tissue,
SPECT allows the regional cerebral blood flow to be
studied in different tissues in various physiological and
pathological states. The local perfusion is often reduced
between seizure attacks, and the blood flow markedly
increases during or soon after seizures. Typical
findings from SPECT studies provided supportive
information on focus localisation. Equivocal results,
however, did not preclude surgery.
The Wada (Amytal) test
The intracarotid injection of amobarbital 75 to 125 mg
(amylobarbitone [Amytal; Flynn, Harrow, United
Kingdom]), by using selective digital subtraction
angiography and selective catheterisation techniques,
produced selective hemispheric inactivation and
was used to define hemispheric language and memory
functions. Each carotid artery was catheterised under
Fig 1. T2-weighted coronal section magnetic
resonance image showing right hippocampal sclerosis
Note the atrophy of the hippocampus over the right medial
temporal lobe
R L
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radiological guidance and injected with amobarbital,
during which both language and memory functions,
now only supported by the contralateral ‘active’ cere-
bral hemisphere, were assessed with standardised tests.
A memory retention score above 60% was considered
adequate to support the memory function after the
operation. If the proposed resection area was found to
be in the language-dominant hemisphere or if the con-
tralateral hemisphere could not alone support memory,
resection was either contra-indicated or modified.
Neuropsychological assessment
Preoperative psychological assessment offered insight
into the patients’ perception of the disease and under-
standing of the potential implications of surgical
treatment. Cognitive changes after unilateral temporal
resection can be predicted and used to guide post-
operative rehabilitation. Neuropyschological functions,
such as verbal and non-verbal memory, and attention
and cognitive processing speed, were assessed using
the revised Wechsler adult intelligence scale and the
revised Wechsler memory scale. Only patients whose
performances were within or above the normal range
were selected for surgical resection. Understanding
the patients’ psychological make-up and expectations
enabled us to offer the appropriate preoperative
counselling.
Operative procedures
The operation was performed under general anaesthe-
sia with the use of standard microsurgical techniques.
A curvilinear scalp incision was made behind the
hairline to achieve the best cosmetic results. A tem-
poral craniotomy was performed to gain access to
the anterior temporal lobe. The extent of resection
was tailored for each patient based on preoperative
assessment findings. In general, the anterior tip of the
temporal lobe, the mesial structures (eg amygdala,
hippocampus) and a variable amount of the lateral
temporal cortex were resected. Resections of the ‘non-
dominant’ hemisphere with regards to language and
memory functions would include a greater amount
of the lateral cortex to achieve better seizure control
whereas resection of the ‘dominant’ hemisphere would
be more conservative to minimise the chance of
incurring postoperative dysfunctions (Fig 2). After
the operation, the patients resumed their preoperative
antiepileptic drug therapy.
Patient follow-up
Patients were followed up at the Epilepsy Surgery
Clinic, which is conducted jointly by the neurosurgeons
and neurologists of the QMH. The mean duration of
follow-up was 21.5 months (range, 6-47 months). The
extent of seizure control was evaluated by using a
modified version of Engel’s criteria (Box 2).16 Patients
who were seizure-free would have their medication
gradually reduced. Those who experienced persistent
seizure or recurrence after a seizure-free interval would
have their regimens modified based on individual
assessment.
Results
Eleven patients (seven women and four men) fulfilled
the study selection criteria (Table 1). Their mean age
at surgery was 28 years (range, 19-49 years). All but
one patient (patient 3) had long-standing medically
intractable temporal lobe epilepsy; patient 3 had long-
standing petit mal and hyperkinetic seizure. The
duration between the onset of seizure and surgery
ranged from 12 to 27 years (mean, 17.2 years). A
total of 12 resections (eight right-sided and four left-
sided) were performed; one patient required a second
operation on the same side 2 years after the initial
resection (patient 8).
Seizure control
The results of seizure control after surgery are shown
in Table 2. Seizure control was assessed at fixed inter-
vals of 6 months (three patients), 1 year (three patients)
or 2 years (five patients) after the operation. Two
(18%) patients were seizure-free without needing
Fig 2 . Postoperative T2-weighted axial magnetic
resonance image after a right-sided temporal lobe
resection
R L
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medication (group Ia). One of them (patient 8) had
undergone a left-sided resection 2 years previously but
with unsatisfactory outcome (group III); only the
anterior portion of the medial temporal structures and
a small amount of the lateral cortex had been resected
in the first operation. Marked improvement was seen
in this patient after the second ipsilateral temporal
lobe resection, in which a temporal lobectomy was
performed to a posterior margin of 5 cm from the
temporal pole. Six (55%) patients were seizure-free
while remaining on the preoperative or reduced regi-
men of antiepileptics (group Ib). Two (18%) patients
experienced greater than 90% of improvement in their
seizure control (group II). One (9%) patient had less
then 90% but greater than 50% of improvement (group
III). This patient (patient 3) had a history of psychi-
atric illness and psychosocial adjustment disorder.
Postoperative EEG studies, however, did not demon-
strate any clear correlation between cortical activities
and the persistent ‘seizures’. Pseudoseizure was diag-
nosed and this patient’s response to surgery thus could
not be reliably assessed. No patients were classified
as belonging to group IV or V. Nine (81%) patients
experienced either significant or noticeable improve-
ment in their overall function and performance of daily
activities. Two (18%) patients reported no improve-
ment or worsening after surgery: one of them (patient
3) had poor seizure control (group III) and the other
(patient 4) had experienced deterioration in memory
function postoperatively.
Surgical complications
There were no mortalities or major postoperative com-
plications in this series of patients. One (9%) patient
had transient vocal cord palsy and hoarseness, which
was most probably related to endotracheal intubation
during induction of general anaesthesia (patient 11).
The patient recovered fully after receiving conserva-
tive treatment. One (9%) patient had asymptomatic
upper quandranopia contralateral to the side of resec-
tion, as detected by postoperative visual field testing
(patient 5). Two (18%) patients had symptomatic per-
manent deficits: one of them had persistent paralysis
of the frontalis muscle ipsilateral to the resected
side, which was caused by inadvertent injury to the
frontal branch of the facial nerve during the operation
(patient 8). The second patient, who had undergone
a right-sided resection, experienced postoperative
deterioration in memory function (patient 4), which
occurred despite the fact that the results from the
preoperative Wada test indicated left-hemisphere
language dominance and 100% memory retention on
right-hemisphere inactivation. No other patients had
functionally significant memory or language deficits.
Discussion
Patient selection is one of the most important factors
in determining the success of surgery for epilepsy.
During the early phase of the Epilepsy Surgery Pro-
gramme, we deliberately selected patients who had a
more predictable response to surgery—namely, those
who had intractable complex partial seizure of tem-
poral lobe origin. Surgical results are most promising
for patients with temporal lobe epilepsy; the success
rate is 81%, compared with 50% for patients with
frontal lobe seizure.14
All but two of the patients in this series had pre-
operative evidence of hippocampal sclerosis, which is
a strong predictor of excellent postoperative seizure
control.17,18 The characteristic features of hippocampal
sclerosis are local atrophy and gliosis of the mesial
temporal structures—namely, the uncus, amygdala,
anterior hippocampus, and hippocampal gyrus. It has
Box 2. Seizure outcome evaluation16
Group Ia Seizure-free without medication
Group Ib Seizure-free with medication
Group II ≥90% reduction of seizure
Group III <90% but >50 % reduction of seizure
Group IV No change from baseline
Group V Deterioration
Table 2. Surgical outcome: seizure control and postoperative complications
Patient Operation date Resection Postoperative Seizure-control Complications
assessment group
1 Aug 1994 Right 2 years Ib None
2 Jan 1995 Left 2 years Ib None
3 Jul 1995 Right 2 years III None
4 Apr 1996 Right 2 years Ib Memory decline
5 Dec 1996 Right 2 years II Visual field defect
6 May 1997 Left 1 year Ia None
7 Jul 1997 Right 1 year Ib None
8 Oct 1995, Nov 1997 Left 1 year Ia Frontalis paralysis
9 Feb 1998 Right 6 months Ib None
10 Apr 1998 Right 6 months II None
11 May 1998 Right 6 months Ib Vocal cord palsy
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been suggested that during head moulding at birth,
herniation of the medial temporal gyri through the
incisura of the tentorium cerebelli results in ischaemic
damage.19 It has also been suggested that the neuronal
damage associated with hippocampal sclerosis is the
result of consumptive hypoxia due to severe febrile
convulsion in infancy.20 The subsequent cell loss
might stimulate the synaptic reorganisation of the
remaining neurones, which could give rise to abnor-
mal discharges that eventually propagate sufficiently
to produce clinical seizure.21 Surgical resection of the
damaged areas of the brain affected by hippocampal
sclerosis—the anterior and medial temporal lobe—
is effective in eradicating seizure.22 In addition, the
presence of hippocampal sclerosis and mesial tem-
poral damage may result in the abnormal displacement
of memory function to the contralateral hippocampus,
which may then help protect against postoperative
memory deterioration.22 Conversely, resection of an
intact temporal lobe can be associated with significant
memory decline.23
Comparing the results of surgery for epilepsy in
different hospitals is difficult because patient selec-
tion, operative approaches, and criteria for outcome
assessment vary widely. Engel et al16 reviewed 3579
patients from 100 epilepsy centres and found signifi-
cant clinical improvement in 92% of the patients. The
proportion of patients who remain seizure-free after
temporal lobe resection is approximately 70%.6,24,25 In
our series, 73% (8/11) of the patients were seizure-
free with or without the need for medication (patients
in groups Ia and Ib) and significant improvement was
found in 91% (10/11) of patients (groups I and II). The
majority (5/6) of the patients who became seizure-
free by taking reduced dosages of their preoperative
antiepileptics (group Ib), reported that being able to
control their seizure with drug therapy has made a
tremendous impact on their overall physical and psy-
chological functioning. These results are encouraging,
but the fact that these patients were a highly selected
group compared with those in larger series has to be
considered. Furthermore, our follow-up duration was
relatively short (mean, 21.5 months). In general, follow-
up of at least 6 months to 1 year is required before
the outcome of surgery for epilepsy can be reliably
assessed.3 Seizure control in the second postoperative
year should predict the 5-year outcome.25
Our current selection criteria may have excluded
some patients who could have otherwise undergone
and benefitted from surgery. In the past, performing
surgery to manage epilepsy was largely limited to
lesionectomy (eg excision of post-traumatic scaring
or tumour). The development of MRI and modern
EEG techniques has greatly increased the number
of patients who may benefit from surgery. The
current gold standard of focus localisation that would
predict a favourable outcome involves the demonstra-
tion of regional activation on inter-ictal and ictal
EEG scans and focal abnormalities, especially hippo-
campal sclerosis, on MRI scans.18 Some patients
may not demonstrate these features on initial evalu-
ation but they are by no means excluded from further
consideration for surgical treatment. The use of multi-
modality investigations allows the better identification
of any isolated epileptic foci by providing valuable
supportive information. For instance, in our series,
all but two patients showed unilateral temporal foci
according to the results of EEG telemetry. The
remaining two patients (patients 4 and 7) had bilateral
temporal discharges on inter-ictal and ictal EEG
scans. There were, however, unequivocal findings
of right-sided hippocampal sclerosis on MRI, and
right-sided inter-ictal hypoperfusion on SPECT. Both
patients had good outcome after right-sided resection
(group 1b). In other centres, more invasive techniques
such as direct brain recording using subdural grid
electrodes or multicontact depth electrodes are
used.26,27 Although these procedures are associated with
increased surgical risks, they have enhanced the
selection of patients with genuinely localised foci
who are amendable to surgical treatment.
Recurrent or persistent seizure constitutes surgical
failure and the most important cause is insufficient
resection (and hence, for example, retained mesial
structures).28 Other causes of treatment failure include
localisation error (eg bitemporal or extratemporal
foci), and the development or activation of a separate
focus.29 Results of reoperation are good,28 as demon-
strated by one of the patients in this series, who had
a poor outcome after the first, more ‘conservative’
resection, which was most likely due to retained
epileptogenic structures. More extensive resection
including more of the lateral cortex and mesial tem-
poral structures in the second operation had resulted
in much improved outcome.
Complications of cortical resection to manage
epilepsy are not common. The incidence ranges from
1%30 to 16%.31 One of the patients in this series had
mild bilateral upper quandranopia postoperatively;
this is a well-recognised complication of temporal
lobectomy and is caused by damage to the Meyer’s
loop of optic radiation in the temporal lobe. Other
major complications that are specific to temporal lobe
resection are postoperative memory and language
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dysfunction. One of the main objectives of preoperative
assessment is to ascertain whether the proposed area
of resection is dispensable with respect to memory
and language functions. Although the Wada test is a
widely used technique, concern has been raised
regarding its reliability.32 The reason for the signifi-
cant postoperative memory dysfunction experienced
by one of the patients in this series is unclear. The
results of this patient’s preoperative Wada test showed
that the hemisphere contralateral to the resection side
was able to fully support memory. And the results of
the postoperative memory test actually contradicted
the patient’s subjective complaints, thus suggesting
that a significant part of his ‘memory decline’ was
psychogenic. This patient had had intractable epilepsy
for 13 years and became seizure-free (group Ib)
after surgery. The sudden removal of a ‘sick role’ may
have resulted in certain difficulties in psychosocial
adjustment. This case shows that surgery for epilepsy
can alter only the control and frequency of seizure but
not other dysfunctions that result from a prolonged
period of uncontrolled seizure. Surgical treatment
should be considered at an early stage of the disease,
before these dysfunctions are permanently established.
For complex partial seizure, an adequate medical
trial involves the use of phenytoin and carbamazepine,
both alone or in combination at dosages to attain
appropriate serum levels; second-line antiepileptics
can then be added for 1 to 2 years.3 Most patients
who respond favourably to drug treatment would
have done so by the first year of treatment. If not, the
possibility of medical intractability should be enter-
tained and surgical treatment seriously considered. In
our series of patients, the duration between the onset
of seizure and surgery was prolonged, because the
Epilepsy Surgery Programme at the QMH commenced
only in 1993.
In conclusion, surgery can produce significant
improvement in patients who have medically intra-
ctable epilepsy. The associated risks are relatively small
and justifiable in view of the benefit of treatment
and harmful consequences of long-term uncontrolled
seizure. By adopting more advanced techniques such
as direct brain-recording, we hope to be able to broaden
the selection criteria provide successful treatment to
more patients in the future.
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industry in Hong Kong enrolled with the School – learning new skills and enhancing their promotion prospects.
The School offers postgraduate courses leading to:
• Master of Health Administration (3 years part-time)
• Graduate Certificate in Health Services Management (one year part-time)
• Doctor of Philosophy (PhD)
In 2000, a limited number of Higher Education Contribution Scheme (HECS) places are available for Australian
citizens or residents. This means a considerable saving on the cost of your education by enrolling in the year 2000.
All programs are available through Distance Education and are undertaken on a part-time basis. You can
begin your course either at the start of Session 1 (February/March) or the start of Session 2 (July/August).
For further information visit our website:< www/med.unsw.edu.au/shsm/>. You can contact us direct by
telephone: 61 2 9385 2591; fax: 61 2 9385 1036; or e-mail: <d.kennedy@unsw.edu.au> or alternatively contact
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